{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:02:30Z","timestamp":1760979750968},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ijrobp.2004.02.026","type":"journal-article","created":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T20:30:36Z","timestamp":1093984236000},"page":"302-309","source":"Crossref","is-referenced-by-count":24,"title":["Assessment and management of cutaneous reactions with amifostine administration: Findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP)"],"prefix":"10.1016","volume":"60","author":[{"given":"Ralph","family":"Boccia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramila Rani","family":"Ann\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Brizel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Nathaniel","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Hymes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Koukourakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Kozloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2004.02.026_BIB1","series-title":"Head and neck cancer: A multidisciplinary approach","first-page":"151","article-title":"Dental oncology and maxillofacial prosthetics","author":"Zlotolow","year":"1999"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB2","unstructured":"Ethyol (amifostine) prescribing information. Gaithersburg, MD: MedImmune Oncology, Inc.; 2001"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(01)02683-9","article-title":"Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer","volume":"52","author":"Antonadou","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB4","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1008282412670","article-title":"Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer","volume":"9","author":"Buntzel","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB6","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1200\/JCO.1999.17.10.3333","article-title":"American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants","volume":"17","author":"Hensley","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB7","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1200\/JCO.2002.04.178","article-title":"2002 update of recommendations for the use of chemotherapy and radiotherapy protectants","volume":"20","author":"Schuchter","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB8","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1200\/JCO.2000.18.11.2226","article-title":"Subcutaneous administration of amifostine during fractionated radiotherapy","volume":"18","author":"Koukourakis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/sonc.2002.37346","article-title":"Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer","volume":"29","author":"Anne","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992)","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB11","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB12","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy","volume":"353","author":"Rzany","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB13","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1001\/jama.1997.03550220101014","article-title":"Allergic reactions to drugs and biologic agents","volume":"278","author":"deShazo","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2340\/0001555576385386","article-title":"Cutaneous reactions after treatment with 2-chlorodeoxyadenosine","volume":"76","author":"Meunier","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2257.2000.00283.x","article-title":"Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution","volume":"22","author":"Grey","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB17","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1200\/JCO.2000.18.19.3384","article-title":"Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer","volume":"18","author":"Talamonti","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1742-1241.1999.tb11707.x","article-title":"5-fluorouracil-induced erythema multiforme","volume":"53","author":"Lo","year":"1999","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/j.1552-4604.1989.tb03426.x","article-title":"Stevens-Johnson syndrome, respiratory distress and acute renal failure due to synergic bleomycin-cisplatin toxicity","volume":"29","author":"Brodsky","year":"1989","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/030089168607200316","article-title":"Stevens-Johnson syndrome and fatal pulmonary toxicity to combination chemotherapy containing bleomycin","volume":"72","author":"Giaccone","year":"1986","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1525-1470.2001.018001038.x","article-title":"Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside","volume":"18","author":"Ozkan","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2340\/0001555574135137","article-title":"Erythema multiforme during GM-CSF therapy","volume":"74","author":"Stasi","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB23","first-page":"355","article-title":"L-asparaginase and toxic epidermal necrolysis","volume":"69","author":"Rodriguez","year":"1980","journal-title":"J Med Assoc Ga"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0190-9622(97)70341-4","article-title":"Stevens-Johnson syndrome associated with topical nitrogen mustard therapy","volume":"36","author":"Newman","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/archinte.1967.04410010113017","article-title":"Hypersensitivity to nitrogen mustards in the form of erythema multiforme. A unique adverse reaction","volume":"120","author":"Brauer","year":"1967","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM197812212992510","article-title":"Toxic epidermal necrolysis after mithramycin","volume":"299","author":"Purpora","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jso.2930260111","article-title":"Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil","volume":"26","author":"Spencer","year":"1984","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-2141.2002.03499.x","article-title":"Stevens-Johnson syndrome after treatment with STI571","volume":"117","author":"Hsiao","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB29","first-page":"4209","article-title":"Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies","volume":"6","author":"Scheulen","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1600-0560.1991.tb01547.x","article-title":"Localized epidermal necrolysis (erythema multiforme-like reaction) following intravenous injection of vinblastine","volume":"18","author":"Arias","year":"1991","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB31","first-page":"48","article-title":"Docetaxel-associated radiation recall dermatitis","volume":"9","author":"Mulder","year":"2002","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB32","first-page":"711","article-title":"Doxorubicin-enhanced skin reaction after whole-body electron-beam irradiation for leukemia cutis","volume":"55","author":"Solberg","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiol.2252011414","article-title":"Minimizing radiation-induced skin injury in interventional radiology procedures","volume":"225","author":"Miller","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1440-1673.1996.tb00414.x","article-title":"Erythema multiforme-like reaction associated with radiotherapy","volume":"40","author":"Veness","year":"1996","journal-title":"Australas Radiol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB35","first-page":"463","article-title":"Erythema multiforme (Stevens-Johnson syndrome) following deep radiation therapy","volume":"51","author":"Ridgway","year":"1993","journal-title":"Cutis"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00007611-199006000-00023","article-title":"Stevens-Johnson syndrome after radiotherapy","volume":"83","author":"Howell","year":"1990","journal-title":"South Med J"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archderm.1997.03890430055008","article-title":"Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome. Contribution of perforin-positive cell infiltration","volume":"133","author":"Inachi","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0360-3016(95)00214-8","article-title":"Radiation-induced apoptosis","volume":"33","author":"Dewey","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0190-9622(99)70508-6","article-title":"Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital","volume":"40","author":"Duncan","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB41","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1346-8138.1997.tb02524.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme","volume":"24","author":"Roujeau","year":"1997","journal-title":"J Dermatol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB42","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(00)03137-8","article-title":"Idiosyncratic drug reactions","volume":"356","author":"Knowles","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB44","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archderm.1995.01690230046008","article-title":"Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome","volume":"131","author":"Cote","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981\u20131985","volume":"126","author":"Roujeau","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2004.02.026_BIB47","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00007611-199610000-00015","article-title":"Cyclophosphamide in the treatment of toxic epidermal necrolysis","volume":"89","author":"Frangogiannis","year":"1996","journal-title":"South Med J"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604003207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604003207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T08:35:58Z","timestamp":1705221358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301604003207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0360301604003207"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2004.02.026","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}